Schwazze Reports Slight Revenue Drop In Q4 2023 Amid 'Fierce' Competition In Cannabis Retail Sector
Schwazze Reports Slight Revenue Drop In Q4 2023 Amid 'Fierce' Competition In Cannabis Retail Sector
Schwazze报告称，在大麻零售业的 “激烈” 竞争中，2023年第四季度收入略有下降
Medicine Man Technologies, Inc. (OTC:SHWZ), operating as Schwazze, announced its financial and operational results on Thursday for the fourth quarter and full year ended Dec. 31, 2023.
以施瓦兹的名义运营的Medicine Man Technologies, Inc.（场外交易代码：SHWZ）周四公布了截至2023年12月31日的第四季度和全年财务和经营业绩。
"This past year, the Schwazze team delivered solid top-line growth in two highly competitive markets with 31% adjusted EBITDA margins and improved operating cash flow," said Forrest Hoffmaster, interim CEO of Schwazze. "We continued to sharpen our retail strategy while expanding our store footprint by more than 50% to 63 dispensaries across our two markets."
施瓦兹临时首席执行官福雷斯特·霍夫马斯特表示：“去年，施瓦兹团队在两个竞争激烈的市场实现了稳健的收入增长，调整后的息税折旧摊销前利润率为31％，运营现金流有所改善。”“我们继续完善零售战略，同时将门店占地面积扩大了50％以上，达到两个市场的63家药房。”
"Although the Colorado and New Mexico markets were pressured in 2023, we have built a solid foundation with best-in-class service...
“尽管科罗拉多州和新墨西哥州的市场在202...
登录免费看全文
登录/注册